InkVivo Technologies AG


InkVivo Technology AG is a Swiss biotech company and it has developed a multistructural approach for the effective (re)formulation of drug delivery systems. To our industrial partners, we provide several effective opportunities to reformulate drugs and to extend the life cycle of existing products.

We combine our patented nanomatrix polymer platform with advanced and scalable manufacturing process. Independent of the route of adminstration, InkVivo enables the possiblity to co-formulate active ingredients (e.g., small molecules with biologics), to tailor the temporal release kinetic of each ingredients, and to target specific biological tissues and organs. In vitro and in vivo experiments have demonstrated our technology to be safe and to ensure prolonged localized retention as well as bioavailability.